What top creators are saying about TG Therapeutics(TGTX)
A biotech company with a treatment for Multiple Sclerosis (MS) called Briumvi.
3 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about TG Therapeutics in the last 30 days yet.
Top creators covering TG Therapeutics (TGTX)
The 1 sources with the most insights about TG Therapeutics on Kazuha.
Latest insights about TG Therapeutics (TGTX)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, November 3, 2025
The company has a strong competitive moat with its drug Briumvi, effectively creating a duopoly with patent protection until 2042. The stock is viewed as a compelling investment and a future 'cash cow', with the recent price drop after strong earnings seen as a buying opportunity.
Sunday, September 7, 2025
A 'rent-seeking' play with a strong regulatory moat, as its drug Briumvi has market exclusivity until 2042. It has the potential for 10x revenue growth by 2030 by capturing market share.
Wednesday, August 6, 2025
The speaker is very bullish, stating the stock is 'poised to bounce' after a 20% drop. It operates in a protected oligopoly, has raised guidance, and is considered 'cheap' with a Rule of 40 score of 72.
Monday, November 3, 2025
The company has a strong competitive moat with its drug Briumvi, effectively creating a duopoly with patent protection until 2042. The stock is viewed as a compelling investment and a future 'cash cow', with the recent price drop after strong earnings seen as a buying opportunity.
Sunday, September 7, 2025
A 'rent-seeking' play with a strong regulatory moat, as its drug Briumvi has market exclusivity until 2042. It has the potential for 10x revenue growth by 2030 by capturing market share.
Wednesday, August 6, 2025
The speaker is very bullish, stating the stock is 'poised to bounce' after a 20% drop. It operates in a protected oligopoly, has raised guidance, and is considered 'cheap' with a Rule of 40 score of 72.
Discussed alongside TG Therapeutics (TGTX)
Other assets that creators frequently mention in the same content as TG Therapeutics.
Frequently asked
Which podcasters and creators cover TG Therapeutics (TGTX) the most?
The most active sources covering TG Therapeutics (TGTX) on Kazuha are @BeatTheDenominator. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about TG Therapeutics (TGTX) are on Kazuha?
Kazuha has indexed 3 AI-extracted insights about TG Therapeutics (TGTX) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside TG Therapeutics (TGTX)?
Creators covering TG Therapeutics (TGTX) most frequently also discuss ODD, ELF, REAX, DCTH, NVO. See the "Discussed alongside" section above for full asset pages.